Pilot Grants Program

Pilot Grants Program is sponsored by National Institute on Aging (NIA) Imbedded Pragmatic Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) Clinical Trials (IMPACT) Collaboratory. This program funds pilot embedded pragmatic clinical trials (ePCTs) of non-pharmacological interventions within health care systems to improve the care of people living with dementia (PLWD) and their care partners.

Pilot Grants Program - NIA IMPACT Collaboratory The National Institute on Aging (NIA) Imbedded Pragmatic Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD) Clinical Trials (IMPACT) Collaboratory (U54AG063546) was established in 2019 to build the nation’s capacity to conduct embedded pragmatic clinical trials (ePCTs) of non-pharmacological interventions within health care systems to improve the care of people living with dementia (PLWD) and their care partners.

The IMPACT Collaboratory Pilot Grant Program funds pilot ePCTs that are designed to demonstrate the feasibility and inform the design of a future full-scale ePCT (Stage IV effectiveness based on the NIH Stage Model ) to evaluate non-pharmacological interventions embedded in health care system(s) for PLWD and their care partners.

The IMPACT Collaboratory provides guidance for investigators in the design, conduct, and dissemination of ePCTs through its Cores. Funding Opportunity Description The IMPACT Collaboratory will fund up to three pilot ePCTs that are designed to demonstrate the feasibility and inform the design of a future full-scale ePCT for people living with dementia and their care partners.

All applications must make a convincing case that the proposed pilot ePCT, if successful, can be scaled to a full-scale ePCT as the next research step. Required features of the study design are delineated below under General Requirements for Pilot ePCT Application. Awards are for 18 months, up to $300,000 (total direct costs), and are non-renewable.

Indirect costs are budgeted at your institution's negotiated facilities and administrative rate. Only a single Principal Investigator is allowed, and only one application per Principal Investigator is permitted in a single funding cycle. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this funding opportunity.

Request for Applications | RFA-IMPACT-P2026 Request for Applications – Released Letters of Intent Due – Required July 23, 2026 @ 11:59 pm ET November 19, 2026 @ 11:59 pm ET General Requirements for Pilot ePCT Application Expand Applications to the Pilot Grant Program must propose pilot ePCTs that have the following design features: Propose a pilot ePCT to assess the feasibility of a full-scale ePCT evaluating a non-pharmacological intervention targeting PLWD and/or their care partners.

Address an area relevant to PLWD, care partners, or the health care providers caring for them. Evaluate an intervention with a reasonable level of evidence demonstrating its efficacy from prior randomized clinical trials (e.g., NIH Stage II/III trial). The level of evidence of efficacy is less stringent for simple or “nudge” (versus complex/multicomponent) interventions.

Include at least two study arms: an intervention arm and a comparator arm (e.g., routine care, enhanced routine care, or another appropriate comparison condition). Applicants should justify the choice of comparator and its relevance to routine practice. Randomization is required.

Include settings with two or more health care systems or sites within health care systems (e.g., nursing homes, hospitals, health care provider practices). The number of sites and participants (i.e., sample size) should be determined based on a high degree of confidence that key feasibility endpoint targets are met. Pilot ePCTs should NOT be powered to demonstrate efficacy or effectiveness of the intervention.

Whenever possible and appropriate, the pilot ePCT should be designed to qualify for a waiver or alteration of informed consent in accordance with Federal regulation 45 CFR §46. 116(f)(3)(i. -v.)

. Informed consent may still be needed for ancillary study activities, such as qualitative interviews with participants or limited primary data collection. Evaluate the feasibility of a participant identification and enrollment strategy that aligns with an ePCT design, i.e., typically leverages real-world or existing data sources with minimal to no active screening or recruitment by research personnel.

Projects must include a plan for ongoing monitoring of the accuracy and success of the participant identification and enrollment strategy in terms of reaching anticipated target goals in both the intervention and comparator arms.

Evaluate an intervention that can be implemented with fidelity in a health care system using strategies that align with an ePCT design, i.e., typically implemented within routine care and workflows (e.g., by providers) with minimal to no involvement by research personnel.

Provide an evaluation plan for ongoing monitoring of intervention implementation, including assessment of adherence of delivery of core intervention components and consistency across sites. Specify and evaluate the feasibility of collecting a single primary clinical outcome that will ultimately be used to evaluate the effectiveness of the intervention in a future full-scale ePCT.

The primary clinical outcome should be 1) clinically relevant to PLWD, their care partners and/or their health care providers, and 2) efficiently captured with minimal need for additional follow up, resources, or impact on routine care (i.e., in alignment with an ePCT design).

Specify quantitative feasibility endpoints indicating the success of the strategies proposed to 1) identify/enroll participants, 2) implement the intervention, and 3) collect the primary clinical outcome. Demonstrating that each of these strategies are successful supports the feasibility of a full-scale ePCT. Address biologic variable of sex as it relates to populations and outcomes.

Informational Webinar Expand An informational webinar provides investigators with an overview of application details. Pilot Grant Program Webinar Overview Interested applicants are required to submit a Letter of Intent (LOI) through the Brown University UFunds system at: https://ufunds. brown.

edu . LOIs may be submitted no later than Thursday, July 23, at 11:59pm ET . Access to UFunds: UFunds can be accessed either with a Brown University email address or with a Gmail address that has been granted rights to the system.

The PI may request Gmail access, or someone else may request permission to submit on behalf of a PI. UFunds is not a multi-user environment. If the PI needs more than one person to work on the application in UFunds, contact Faye_Dvorchak@brown.

edu to discuss a possible workaround prior to requesting access to UFunds. Investigators who were previously granted access to UFunds may use their credentials. New users are required to request access to the UFunds system using a Gmail address via https://tinyurl.

com/UFundsAccess . Upon approval, an invitation will be issued to the Gmail address provided. Please note that the registration process may require up to 2 business days; applicants are advised to initiate their request as early as possible.

There is a competitive two-step application process: The LOI application for the Pilot ePCT includes the following main elements. ( Please use this template ) B. Overview of Pragmatic Pilot ePCT Design D.

Setting(s) (types and names of health care systems) E. Participants including the Identification and Enrollment Strategy F. Intervention Structure and Content G.

Intervention Implementation Strategy, and H.

Clinical Outcome Definitions and Collection Strategy Bibliography and References Cited (up to 10 and no more than 1-page; not included in the 2-page limit above) Attestation in UFunds that Principal Investigator has read: ­ RAPT Model: Describes if the intervention is READY for an ePCT ­ PRECIS-2 Framework : Describes key DESIGN elements in an ePCT NIH Biosketches for Principal Investigator(s) STEP 2: Full Proposals by Invitation Only Applications selected for further consideration will be invited to submit a full proposal that will be due no later than Thursday, November 19, 2026, at 11:59PM ET .

Invited applicants will receive an Application Guide with detailed instructions on all required components. Applications that are not aligned with an ePCT design will be administratively triaged prior to review. Pilot ePCTs for intervention generation/refinement (i.e., Stage I on NIH Stage Model ) or efficacy trials (i.e., Stage II/III on NIH Stage Model ) will NOT be considered.

Consultation from IMPACT Expand Applicants invited to submit a full proposal will have two one-hour meetings with an IMPACT Consultation Team during the application preparation period. The Team is comprised of experts from IMPACT Cores and is assembled specifically for each proposal. The purpose of the consultations is to help applicants prepare the strongest and most rigorous application.

The applicant and the project biostatistician must attend both meetings. Prior to the first meeting, the Consultation Team Lead will provide a form with structured feedback based on the LOI. This form will be discussed during the first consultation meeting.

The applicant will have an opportunity to ask questions and receive guidance. One week before the second meeting, the applicant will submit a draft of the Specific Aims. These draft aims will be discussed at the second consultation meeting, offering a further opportunity for feedback and guidance.

Investigator Navigator Team Expand The IMPACT Investigator Navigator Team can facilitate additional one-on-one individual consultations between the applicant and experts from specific IMPACT Cores (e.g., Design and Statistics, Implementation) at any time during the proposal preparation period. All inquiries for consultation from Cores should be addressed to the Investigator Navigator Team at IMPACTnavigator@hsl. harvard.

edu . Long-Term Care Data Cooperative Expand Investigators interested in conducting a pilot ePCT in the long-term care setting who do not already have an established relationship with a provider group are encouraged to explore opportunities with the Long-Term Care Data Cooperative (LTCDC). Additional information about the LTCDC is available through the informational video series .

Investigators seeking to explore whether their pilot ePCT aligns with the interests of facilities participating in the LTCDC should contact the Investigator Navigator Team at IMPACTnavigator@hsl. harvard. edu .

Applicants considering using the LTCDC for their pilot ePCT should be aware that additional time will be required to submit a separate application to LTCDC and receive the required approvals to use this resource. Frequently Asked Questions Expand A set of frequently asked questions can be found on this page: Pilot Grant FAQ.

Required Materials and Resources (opens in new tab) Pilot Grant Program Webinar Overview Pilot Grant Application Due